Affinity Asset Advisors LLC Has $3.33 Million Stock Holdings in NewAmsterdam Pharma (NASDAQ:NAMSW)

Affinity Asset Advisors LLC boosted its stake in NewAmsterdam Pharma (NASDAQ:NAMSW) by 11.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 237,935 shares of the company’s stock after buying an additional 24,961 shares during the period. Affinity Asset Advisors LLC’s holdings in NewAmsterdam Pharma were worth $3,331,000 as of its most recent filing with the SEC.

Separately, Wolverine Asset Management LLC bought a new stake in shares of NewAmsterdam Pharma during the fourth quarter worth approximately $181,000.

NewAmsterdam Pharma Trading Up 18.2 %

Shares of NASDAQ NAMSW opened at $8.05 on Tuesday. The business’s 50 day moving average is $9.68 and its 200-day moving average is $10.64. NewAmsterdam Pharma has a 1-year low of $5.45 and a 1-year high of $16.75.

NewAmsterdam Pharma Company Profile

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases.